Skip to main content
Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.32
+0.16 (1.22%)
At close: Apr 28, 2026, 4:00 PM EDT
13.26
-0.06 (-0.45%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Organon & Co. Revenue

In the year 2025, Organon & Co. had annual revenue of $6.22B, down -2.92%. Organon & Co. had revenue of $1.51B in the quarter ending December 31, 2025, a decrease of -5.34%.

Revenue (ttm)
$6.22B
Revenue Growth
-2.92%
P/S Ratio
0.56
Revenue / Employee
$621,600
Employees
10,000
Market Cap
3.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.22B-187.00M-2.92%
Dec 31, 20246.40B140.00M2.24%
Dec 31, 20236.26B89.00M1.44%
Dec 31, 20226.17B-130.00M-2.06%
Dec 31, 20216.30B-228.00M-3.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pfizer 62.58B
Sanofi 54.60B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
GSK plc 43.97B
Amgen 36.75B
Gilead Sciences 29.44B
Biogen 9.89B
Revenue Rankings

OGN News

More News